expand Madrigal Pharmaceuticals' NASH pill Rezdiffra is FDA-approved treatment for the fatty liver disease. Madrigal Pharrmaceuticals "I will ask you to look at any [new drug] launch," said Sibold ...
Analyst Jonathan Wolleben of JMP Securities reiterated a Buy rating on Madrigal Pharmaceuticals (MDGL – Research Report), with a price target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback